Instrument Inactif

Autres langues Akcea Therapeutics, Inc.

Actions

AKCA

US00972L1070

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Aspen Neuroscience, Inc. Appoints Lisa Johnson-Pratt as Senior Vice President, Therapeutic Program Lead	14/02
Mersana Therapeutics, Inc. Announces Carla Poulson as Chief Human Resources Officer	19/01/21
Ionis Pharmaceuticals : Akcea Therapeutics - WAYLIVRA, the first and only therapy for familial chylomicronaemia syndrome, to be available on the NHS in Scotland	10/11/20
Ionis Pharmaceuticals : and Akcea Recognize FCS Awareness Day with Global Community Efforts to Celebrate Unsung Heroes	09/11/20
Akcea Therapeutics Announces Scottish Medicines Consortium Enabled Access to Volanesorsen on the National Health Service in Scotland for the Treatment of Familial Chylomicronaemia Syndrome	09/11/20
IONIS PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	04/11/20
Ionis Pharmaceuticals : and Akcea announce that Pfizer has initiated a Phase 2b clinical study of vupanorsen	04/11/20
Ionis Pharmaceuticals : and Akcea win prestigious Prix Galien Award for TEGSEDI as Best Biotechnology Product	02/11/20
Ionis Pharmaceuticals : completes acquisition of Akcea Therapeutics	13/10/20
AKCEA THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	13/10/20
Akcea Therapeutics, Inc. Announces Management Changes	13/10/20
IONIS PHARMACEUTICALS INC : Completion of Acquisition or Disposition of Assets, Other Events, Financial Statements and Exhibits (form 8-K)	13/10/20
Akcea Therapeutics : Ionis Pharmaceuticals completes acquisition of Akcea Therapeutics	12/10/20
Akcea Therapeutics, Inc.(NasdaqGS:AKCA) dropped from S&P TMI Index	12/10/20
Akcea Therapeutics, Inc.(NasdaqGS:AKCA) dropped from S&P Global BMI Index	12/10/20
Akcea Therapeutics, Inc.(NasdaqGM:AKCA) dropped from Russell Small Cap Comp Value Index	12/10/20
Akcea Therapeutics, Inc.(NasdaqGM:AKCA) dropped from Russell 2000 Value Index	12/10/20
Akcea Therapeutics, Inc.(NasdaqGM:AKCA) dropped from Russell 2500 Value Index	12/10/20
Akcea Therapeutics, Inc.(NasdaqGM:AKCA) dropped from Russell 3000 Value Index	12/10/20
Akcea Therapeutics, Inc.(NasdaqGM:AKCA) dropped from Russell 2000 Value-Dynamic Index	12/10/20

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Akcea Therapeutics, Inc.

Actions

AKCA

US00972L1070

Autres langues

Filtres